-
公开(公告)号：US20240148893A1
公开(公告)日：2024-05-09
申请号：US18178854
申请日：2023-03-06
发明人： Yasuhiro MATSUMURA , Masahiro Yasunaga , Shinji Saijou , Shingo Hanaoka , Takahiro Anzai , Shino Manabe
IPC分类号： A61K47/68 , A61K39/395 , A61K49/00 , A61P35/00 , C07K16/30 , C12N5/10 , C12N15/09 , C12N15/62 , G01N33/574
CPC分类号： A61K47/6851 , A61K39/395 , A61K49/00 , A61P35/00 , C07K16/30 , C12N5/10 , C12N15/09 , C12N15/62 , G01N33/574 , G01N33/57419
摘要： An object of the present invention is to provide an anticancer drug capable of treating cancer by finding a target molecule specifically expressed in cancer cells and by specifically acting on the target molecule, and to provide a cancer testing method including a step of measuring the target molecule in a sample. The present invention provides an anticancer drug containing, as an active ingredient thereof, an anti-transmembrane protein 180 (TMEM-180) antibody or an antigen-binding fragment thereof. In addition, the present invention provides a cancer testing method including a step of measuring the amount of TMEM-180 in a sample collected from a subject.
-
2.发明公开公开(公告)号：US20240218058A1
公开(公告)日：2024-07-04
申请号：US17915905
申请日：2021-03-30
发明人： Yasuhiro MATSUMURA , Shingo HANAOKA , Shinji SAIJO
CPC分类号： C07K16/18 , A61P9/10 , C12N9/6462 , A61K38/00 , C07K2317/565 , C07K2319/50
摘要： The present invention provides a fusion protein suitable for dissolving a fibrin clot and a pharmaceutical composition containing the fusion protein. According to the present invention, there is provided a fusion protein of an antibody that binds to insoluble fibrin or an antigen-binding fragment thereof and a prourokinase mutant, in which amino acid sequence of a plasmin in a kringle domain is modified so as to be less cleavable with a plasmin, and a pharmaceutical composition containing the fusion protein.
-
公开(公告)号：US11633499B2
公开(公告)日：2023-04-25
申请号：US16083077
申请日：2017-03-07
发明人： Yasuhiro Matsumura , Masahiro Yasunaga , Shinji Saijou , Shingo Hanaoka , Takahiro Anzai , Shino Manabe
IPC分类号： G01N33/574 , C07K16/30 , A61K47/68 , C12N15/09 , C12N5/10 , A61K39/395 , A61K49/00 , A61P35/00 , C12N15/62
摘要： An object of the present invention is to provide an anticancer drug capable of treating cancer by finding a target molecule specifically expressed in cancer cells and by specifically acting on the target molecule, and to provide a cancer testing method including a step of measuring the target molecule in a sample. The present invention provides an anticancer drug containing, as an active ingredient thereof, an anti-transmembrane protein 180 (TMEM-180) antibody or an antigen-binding fragment thereof. In addition, the present invention provides a cancer testing method including a step of measuring the amount of TMEM-180 in a sample collected from a subject.
-
公开(公告)号：US11311626B2
公开(公告)日：2022-04-26
申请号：US16609668
申请日：2018-04-27
摘要： The present invention relates to an antibody-drug conjugate (ADC) and a composition containing the conjugate for use in treating cancer. According to the present invention, provided are an ADC of an antibody specific to insoluble fibrin and a drug in which a linker linking the antibody and the drug has a plasmin cleavage sequence, and a pharmaceutical composition containing the ADC for use in treating cancer.
-
公开(公告)号：US20200147231A1
公开(公告)日：2020-05-14
申请号：US16609668
申请日：2018-04-27
摘要： The present invention relates to an antibody-drug conjugate (ADC) and a composition containing the conjugate for use in treating cancer. According to the present invention, provided are an ADC of an antibody specific to insoluble fibrin and a drug in which a linker linking the antibody and the drug has a plasmin cleavage sequence, and a pharmaceutical composition containing the ADC for use in treating cancer.
-
公开(公告)号：US20200078458A1
公开(公告)日：2020-03-12
申请号：US16578861
申请日：2019-09-23
IPC分类号： A61K39/395 , G01N33/574 , C07K16/30 , A61K39/00 , C07K16/18
摘要： An object of the present invention is to provide an anticancer drug capable of treating cancer by finding a target molecule specifically expressed in cancer cells and by specifically acting on the target molecule, and to provide a cancer testing method including a step of measuring the target molecule in a sample. The present invention provides an anticancer drug containing, as an active ingredient thereof, an anti-transmembrane protein 180 (TMEM-180) antibody or an antigen-binding fragment thereof. In addition, the present invention provides a cancer testing method including a step of measuring the amount of TMEM-180 in a sample collected from a subject.
-
公开(公告)号：US20210221911A1
公开(公告)日：2021-07-22
申请号：US16760539
申请日：2018-10-29
摘要： The present invention provides an antibody beneficial for treatment of a solid tumor, an antibody-drug conjugate thereof, and an anticancer agent comprising these. The present invention provides, for example, an antibody that binds to tissue factor or an antigen-binding fragment thereof, wherein the antibody has a dissociation rate constant kd of 5×10−4 s−1 or more and an association rate constant Ka of 1×104 M−1s−1 or more.
-
8.发明授权公开(公告)号：US11524074B2
公开(公告)日：2022-12-13
申请号：US16578861
申请日：2019-09-23
IPC分类号： A61K39/395 , C07K16/30 , C07K16/18 , G01N33/574 , A61K39/00
摘要： An object of the present invention is to provide an anticancer drug capable of treating cancer by finding a target molecule specifically expressed in cancer cells and by specifically acting on the target molecule, and to provide a cancer testing method including a step of measuring the target molecule in a sample. The present invention provides an anticancer drug containing, as an active ingredient thereof, an anti-transmembrane protein 180 (TMEM-180) antibody or an antigen-binding fragment thereof. In addition, the present invention provides a cancer testing method including a step of measuring the amount of TMEM-180 in a sample collected from a subject.
-
公开(公告)号：US10471146B2
公开(公告)日：2019-11-12
申请号：US15509269
申请日：2015-09-08
IPC分类号： A61K39/395 , G01N33/577 , C07K16/30 , C12N15/13 , C07K16/18 , G01N33/574 , A61K39/00
摘要： An object of the present invention is to provide an anticancer drug capable of treating cancer by finding a target molecule specifically expressed in cancer cells and by specifically acting on the target molecule, and to provide a cancer testing method including a step of measuring the target molecule in a sample. The present invention provides an anticancer drug containing, as an active ingredient thereof, an anti-transmembrane protein 180 (TMEM-180) antibody or an antigen-binding fragment thereof. In addition, the present invention provides a cancer testing method including a step of measuring the amount of TMEM-180 in a sample collected from a subject.
-
公开(公告)号：US20190060480A1
公开(公告)日：2019-02-28
申请号：US16083077
申请日：2017-03-07
发明人： Yasuhiro MATSUMURA , Masahiro YASUNAGA , Shinji SAIJO , Shingo HANAOKA , Takahiro ANZAI , Shino MANABE
IPC分类号： A61K47/68 , A61P35/00 , C12N15/62 , C07K16/30 , G01N33/574
摘要： An object of the present invention is to provide an anticancer drug capable of treating cancer by finding a target molecule specifically expressed in cancer cells and by specifically acting on the target molecule, and to provide a cancer testing method including a step of measuring the target molecule in a sample. The present invention provides an anticancer drug containing, as an active ingredient thereof, an anti-transmembrane protein 180 (TMEM-180) antibody or an antigen-binding fragment thereof. In addition, the present invention provides a cancer testing method including a step of measuring the amount of TMEM-180 in a sample collected from a subject.
-
-
-
-
-
-
-
-
-
搜索结果
16 条记录 (耗时 0.019 秒)
